20 people in Japan have unfortunately died following the intake of a specific, yet undisclosed medication, triggering health alerts nationwide. The precise circumstances surrounding the deaths, including details about the medication in question, are under investigation. Government and health authorities urged the public to exercise caution while using this medicine until further information is available. They've also put medical institutions and pharmacies on high alert to ensure safety measures.

The news has stirred a wave of concern among the Japanese public, which holds a high regard for safety and strict adherence to regulations. Health and life are highly valued in Japan, leading to a strong societal reaction to such issues. The government, medical institutions, and pharmaceutical companies in Japan typically uphold rigorous standards of quality control and public safety in healthcare, which makes this incident even more alarming.

In the US or EU, similar incidents would prompt immediate reaction from health authorities and the public. Regulatory bodies such as the FDA in the US, EMA in the EU would issue safety alerts, possible recalls, and investigations into the incident. Much like in Japan, there would also be public outcry demanding accountability from the involved companies or institutions.